TipRanks
Bioxcel Therapeutics (DE:BX20)
HAMBURG:BX20
Germany Market
BX20
Bioxcel Therapeutics
RESEARCH TOOLSreports

Bioxcel Therapeutics (BX20) Balance Sheet

10 Followers

Bioxcel Therapeutics Balance Sheet

Bioxcel Therapeutics's total assets for Q2 2026 were $28.80M, a decrease of -15.36% from the previous quarter. DE:BX20 total liabilities were $144.26M for the fiscal quarter, a 3.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 44.92M$ 38.34M$ 73.70M$ 205.85M$ 239.44M
Total Liabilities
$ 140.38M$ 131.44M$ 130.21M$ 129.08M$ 17.77M
Total Equity Gross Minority
$ -95.46M$ -93.10M$ -56.51M$ 76.78M$ 221.67M
Other Metrics
Currency in USD

Bioxcel Therapeutics Debt to Assets